
PFE Stock Down 2%, Pfizer to Expand Human Vaccine Trials to Thousands of People
Pfizer (PFE) stock lost 1.94% yesterday but is slightly up today in the pre-market. The company is anticipating to test a COVID-19 vaccine in thousands of people by September.